Investment Committee Chair
Andrew has spent the last 15 years working in the pharmaceutical and biotechnology industries in the UK and has extensive experience in most aspects of these businesses, including compliance, manufacturing, research and development and licensing. He spent from 2002 to 2006 as a Board Director of AIM listed company Allergy Therapeutics plc, which he helped to take to market. He is an experienced angel investor and and also a Director of The OpShop, which helps provide strategic options and opportunities for start-ups and SME’s.
KiwiNet Board Chairman
The Honourable Ruth Richardson, the former New Zealand Minister of Finance, has considerable involvement in the local and international business community chairing the Jade Software Corporation Ltd, SYFT Technologies Ltd, Synlait Ltd and the KULA Fund. Ruth is also a director of Synlait Milk Ltd, NZ Merino Company Ltd and Ruth Richardson (New Zealand) Limited.
Steve leads the university in developing and promoting innovation and commercialisation both nationally and internationally. He is also Director of Perceptive - a leading market research company in NZ. Steve’s previous roles include the CEO of ecentre, the Business Development Centre at Massey University Auckland, which specialises in helping people take their ideas from Garage to Global.
Managing Director of Viclink Ltd
Geoff is the Managing Director of Viclink Ltd. Geoff has extensive and well recognised international skills at raising capital, purchase and sale of technology businesses, joint venture agreements and adding significant commercial value to technology projects. Geoff serves on the Board of a number of technology and medical companies, is a core participant in a start up medical device company and previously had a leading role in the establishment of three technology companies. Geoff is currently the Chair of the Creative HQ Board of Directors. Geoff was General Manager Business Development at IRL for over 10 years.
Bill is Commercial Director, Research and Innovation, at the University of Canterbury, and leads a team providing technology transfer services to the UC faculty. He has extensive business experience, both as an owner-operator and in senior management roles across a range of industries, including farming, food processing, insurance and finance, manufacturing (both heavy and high-tech.), property development, and retailing. He also has a long and wide experience as an Independent Company Director and is an Accredited Fellow of the NZ Institute of Directors.
Plant & Food Research
Dr Gavin Ross has a deep understanding of biotechnology R&D, particularly in the Crown Research environment. He began his career as a research scientist studying the molecular biology of fruit ripening. In 1988 he joined HortResearch (now Plant & Food Research) as a research scientist and in the late 1990s was central to the establishment of genomics research for major horticultural crops, now integral to the Institute’s scientific programmes. After several years with Genesis R&D Corporation, in 2005 Gavin was appointed as HortResearch’s first Vice President Business Development in the USA. Here he was responsible for building the Institute’s US business and liaising with US-based clients and collaborators. In 2010, Gavin returned to New Zealand and is now the General Manager, Business Development with responsibility for the Institute’s global business effort. He is also the Chair of Plant & Food Research’s internal Investment Committee, which is responsible for investing the Institute’s Core Purpose funding from Government. During his career, Gavin has established an international reputation in plant molecular biology and fruit science, and has a strong network of science and industry contacts across New Zealand and the USA.
Dr Andrew Kelly is one of Australia-New Zealand’s most experienced life science investment managers. He is Managing Director and co-founder of BioPacificVentures, a specialist venture capital fund focused on food, health& agriculture. The fund had the New Zealand Government’s Venture Investment Fund as a cornerstone investor as well as the world’s largest food company, Nestlé, and New Zealand’s largest agribusiness, PGG Wrightson. It is a regular co-investor with Europe-based Inventages, the world’s largest investor in this space with over US$1.5 billion under management. Recently Andrew has co-founded BioPacific Partners, a new generation venture firm bringing global life science companies to engage with local innovation.
The first 20 years of Andrew’s career were in science and product development, including General Manager at AgResearch, New Zealand and Director of two research institutes in Australia. He has both Masters and PhD degrees in the life sciences.
Otago Innovation Ltd
David is an experienced commercialisation manager, having worked in the broad area of University technology commercialisation since 2004; much of his current commercialisation focus is around diagnostic biomarkers, physical medical devices and ICT opportunities. Prior to joining Otago Innovation in 2007, David spent a period of time as a Business Manager with FRST, and the University of Otago where he was the Acting Director Enterprise. During this latter period his focus was on the early identification of commercially valuable IP, as well as building the University’s applied research focus. David also has a background in banking and finance, having spent 13 years with the BNZ in the personal and commercial banking environments. David is the Otago Innovation shareholder representative for KiwiNet as well as being a member of the KiwiNet Investment Committee. He also serves on the board of two Otago Innovation spinout companies.
Dr Phil Hart is General Manager Development at Landcare Research. Phil started his career as a soil scientist but has spent the last 18 years in science management and business development. Currently Phil is responsible for investments in science and commercialisation at Landcare Research.
Dr Russell Burton is the General Manager of the Research and Investments Group at Scion with oversight of their Government investments, Māori sector partnership development, the Scion Preseed Accelerator Fund and relationship management with the major Government investors.
Russell is also actively involved in some of the commercialisation activities at Scion. This includes Chairmanship of the Terax 2013 Ltd board an entity charged with commercialisation of the Terax™ waste management technology. His background is in chemical and process engineering initially working in the energy area and later joined the New Zealand forest service where he was involved in their bio-energy programme.
Over his career he has been on the board of several start-up companies and also managed two commercialisation companies. He has also worked for the Development Finance Corporation with commercialisation activities in the USA. Russell is also a Director of the Biopolymer Network Ltd.
Robert heads Cawthron's research investment activities. His role involves matching research with end-users, identifying new business opportunities and working with scientists and investors to realise those opportunities. Robert also leads Cawthron's responses to major Government investment rounds and keeps stakeholders informed of research progress and outcomes. He strongly believes that an open, collaborative approach is key to achieving the best outcomes for New Zealand.
Commercial Manager ESR
Keeping up with new and emerging technology is a constant challenge for any business. Commercial Manager Hamish Findlay says ESR is no exception and the Crown research institute is constantly monitoring developments across a wide range of sectors. “We know that we already have fantastic knowledge and experience here so our focus is on how to apply that to products and projects that will benefit our customers and help them achieve their goals,” Hamish says. Hamish says it’s important for ESR to utilise its own resources, networks and expertise to lead new developments and work with other organisations.
“It’s not just staying across new products and packages but also how people are innovating and adapting, often in ways and places outside their original intent or design.
“Being open to new technology and new partners is very important to us as we look to regularly meet and exceed the expectations of our customers,” Hamish says.
Bryce has a PhD in microbiology and is a graduate of the London Business School Senior Executive Programme. He has held research leader and Regional Manager roles in NIWA, and is currently responsible for overseeing NIWA's strategic initiatives, including commercialisation of research and building partnerships with central and local government and industry.
Neal leads External Relations & Commercialisation at GNS Science and he was appointed in May 2015. He has over 20 years international experience in industry-focussed research and development and commercial technology transfer, with skills in negotiation and strategic management. Before coming to GNS Science he worked with CSIRO, most recently as Group Manager Strategic Alliances. He also worked at Simonsen AS as Technical manager and Comalco as a Senior Research Engineer. Neal holds a PhD in Chemical and Materials Engineering from the University of Auckland.
Chief Technology Officer, Callaghan Innovation
Chris is former Chief Research Officer and Vice President for Lux Research, where he led teams of industry analysts and consultants that provided emerging technology intelligence and strategic advice for the world's leading technology companies.
Prior to joining Lux Research, Chris worked for General Electric, managing global technology programs and product development. He has also held positions as a postdoctoral fellow at the University of North Carolina and as Senior Scientist contracted to the U.S. Naval Research Laboratory's Center for Biomolecular Science and Engineering.
Chris received his Ph.D. in chemistry from the University of Canterbury and is the author of over 25 scientific articles and reviews, and co-inventor of numerous patents in the field of chemical and materials development.
Director, Research Management Office at Lincoln University
Kevin’s background includes research management, new product development (NPD), product management and technology commercialisation. He has experience in the contexts of both commercial and research organisation environments, ranging from start-ups to corporates; and in both private and public sectors.
Kevin’s exposure to a broad range of industry sectors, through engagements and client projects enables him to translate effectively between commercial and science / technical audiences and deliver commercial outcomes from research programmes. Prior to joining Lincoln University, Kevin also worked with Lincoln Agritech Ltd, BioCommerce Centre, Syft Technologies and Landcare Research, amongst others.
Director of the Research and Enterprise, University of Waikato
Simon is the Director of the Research and Enterprise Office at the University of Waikato, leading and managing the operation and functioning of the combined research and enterprise office. The combined office spans the full range of research and enterprise activity from investigator-led and mission led external research contracting and consultancy to industry-led external research contracting, and protecting and commercialising intellectual property generated by staff and students of the University. Simon is responsible for integrating these activities to maximise research and enterprise opportunities and performance for the University. He also provides operational support to the DVC Research and leadership in implementing the University’s research strategy, and leadership of the University’s central research, innovation and commercialisation support infrastructure.